Physician profile
Abby E Starrett
NPI 1952820722
$1,471.10
in general payments reported to CMS, 2019-2025
11 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $263 · 2023: $177 · 2024: $361 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $809.40 | 2021-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA |
| Polynovo North America LLC | $367.10 | 2024-2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $90.67 | 2021 | |
| Davol INC. | $82.54 | 2021-2022 | |
| Ethicon US, LLC | $23.09 | 2022 | |
| Vericel Corporation | $19.76 | 2022 | |
| Teleflex LLC | $18.70 | 2022 | |
| Solventum Corporation | $17.72 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Boston Scientific Corporation | $15.57 | 2024 | Spyglass Discover |
| Kci USA, INC. | $13.92 | 2022 | |
| Kls-Martin L.P. | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Starrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.